Questions a plan sponsor actually asks.
What is Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic used for?
Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic reduces inflammation and suppresses immune responses, used across many conditions.
Is there a generic for Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic?
No. Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic is brand-only with no generic equivalents currently in market.
How much does my plan pay for Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic?
Across 329 Part D plans, Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic averages $4.04/unit (NADAC). Lowest available: $4.04/unit. Highest in distribution: $4.04/unit.
Is Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic on the FDA shortage list?
No. Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic is not currently on the FDA Drug Shortage Database.
4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (1 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.